Circulation

Vol. 151, Issue 18 Issue 18 2025
10
Articles

Articles in this Issue

Aortic Valve Calcification Is Induced by the Loss of ALDH1A1 and Can Be Prevented by Agonists of Retinoic Acid Receptor Alpha: Preclinical Evidence for Drug Repositioning

Mickael Rosa, Annabelle Dupont, David M. Smadja et al. May 06, 2025 pp. 1329-1341 10.1161/circulationaha.124.071954

BACKGROUND: To date, the only effective treatment of severe aortic stenosis is valve replacement. With the introduction of transcatheter aortic valve replacement and extending indications...

MYSTERY-HF: Myeloperoxidase Inhibition in Patients With Heart Failure and Reduced Ejection Fraction: A Phase II Randomized Controlled Trial

Simon Braumann, Sascha Macherey-Meyer, Amin Polzin et al. May 06, 2025 pp. 1372-1374 10.1161/circulationaha.125.074085

Role of Technology in Promoting Heart Healthy Behavior Change to Increase Equity in Optimal Cardiovascular Health: A Scientific Statement From the American Heart Association

Tiffany M. Powell-Wiley, LaPrincess C. Brewer, Lora E. Burke et al. May 06, 2025 10.1161/cir.0000000000001314

Populations most affected by cardiovascular health disparities, including underrepresented populations with lower socioeconomic status, people with disabilities, and those living in underserved rural...

Evidence Generation and Implementation of Transcatheter Interventions for Atrioventricular Valvular Heart Disease in Heart Failure: Current Status and Future Directions

Marco Metra, Daniela Tomasoni, Marianna Adamo et al. May 06, 2025 pp. 1342-1363 10.1161/circulationaha.124.070411

Mitral regurgitation and tricuspid regurgitation are the most common valvular heart diseases in patients with heart failure and have independent prognostic value. Transcatheter interventions are now a...

High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study

Jarett D. Berry, Noor Zabad, Douglas Kyrouac et al. May 06, 2025 pp. 1299-1308 10.1161/circulationaha.124.070335

BACKGROUND: High-volume physical activity (PA) is associated with a higher prevalence of subclinical coronary artery disease (CAD). However, the clinical significance of subclinica...

Letter by Gu et al Regarding Article, “Antisense Oligonucleotide Therapy for Calmodulinopathy”

Siyuan Gu, Ye Chen, Xiaojian Shi May 06, 2025 10.1161/circulationaha.124.073198

Low-Salt Diet <i>and</i> Thiazide Diuretics

Franz H. Messerli, C. Venkata S. Ram, Michel Burnier May 06, 2025 pp. 1297-1298 10.1161/circulationaha.125.074388

Does Coronary Calcium Mean the Same in Active and Sedentary Individuals?

Paul D. Thompson May 06, 2025 pp. 1309-1311 10.1161/circulationaha.125.074396

Response by Bortolin and Pu to Letter Regarding Article, “Antisense Oligonucleotide Therapy for Calmodulinopathy”

Raul H. Bortolin, William T. Pu May 06, 2025 10.1161/circulationaha.125.073965

An NRF2/β3-Adrenoreceptor Axis Drives a Sustained Antioxidant and Metabolic Rewiring Through the Pentose-Phosphate Pathway to Alleviate Cardiac Stress

Lauriane Y.M. Michel, Hrag Esfahani, Delphine De Mulder et al. May 06, 2025 pp. 1312-1328 10.1161/circulationaha.124.067876

BACKGROUND: Cardiac β3-adrenergic receptors (ARs) are upregulated in diseased hearts and mediate antithetic effects to those of β1AR and β2AR. β3AR agonists were recently shown to...

All Issues

Journal Info

Publisher Lippincott Williams & Wilkins
ISSN 0009-7322
E-ISSN 1524-4539
Subject Health Sciences
Language English
View Full Journal Page